Advertisement Alcon names new president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Alcon names new president and CEO

Alcon, an eye care company, has appointed Kevin Buehler as its new president and CEO, effective April 1, 2009. Cary Rayment will retire as president and CEO effective March 31, 2009, but will continue to serve as a director and the nonexecutive chairman of the board.

Mr Buehler is currently senior vice president of global markets and chief marketing officer of Alcon Laboratories, a subsidiary of Alcon. In this capacity, he is responsible for all aspects of the company’s surgical, pharmaceutical and consumer groups, and is integral in the development and execution of corporate strategy.

Mr Rayment said: “I’ve had an exceptionally long and rewarding career at Alcon, and it has been my honor and privilege to lead the company for the last four and a half years as president and CEO. I have the utmost confidence in Kevin’s ability to successfully lead this organization, and I look forward to continue working with the board on the strategic opportunities of Alcon’s business.”